MeSH tree: C12.050
A trans-Tasman clinical trial led by University of Queensland researchers has marked a key step toward easing the kidney dialysis crisis in Australia and New Zealand. The researchers led a large-scale trial to test whether ...
Jul 24, 2026
0
5
New research from the University of South Alabama is shedding light on an emerging bacterial cause of urinary tract infections (UTIs) that appears to be more common along the Gulf Coast than previously recognized.
Jul 24, 2026
0
5
Exposure to a widely used herbicide during the middle months of pregnancy may increase the chance of giving birth too early, before 37 weeks, a new study shows.
Jul 22, 2026
0
4
An Australian woman has given birth to identical quadruplet girls after a pregnancy doctors described as incredibly rare.
Jul 22, 2026
0
7
Women with polyendocrine metabolic ovarian syndrome (PMOS; also known as polycystic ovary syndrome or PCOS) face a fourfold higher risk of heart disease than women without PMOS, according to a new nationwide U.S. study published ...
Jul 21, 2026
0
9
Heart failure already affects more than 60 million people worldwide and is one of the leading causes of hospitalization among people 65 and older. Although it is commonly associated with advanced cardiovascular disease, it ...
Jul 21, 2026
0
6
Discharge day in the neonatal intensive care unit, or NICU, should feel like a finish line. After weeks or months of monitors, alarms, oxygen, feeding tubes, blood tests and waiting, a family can finally take their baby home.
Jul 21, 2026
0
2
Women who experience pregnancy complications such as gestational diabetes, preeclampsia or preterm delivery have a significantly increased long-term risk of developing peripheral artery disease (PAD) later in life, according ...
Jul 21, 2026
0
2
Alongside growing evidence of the domestic spread of such resistant strains in Europe over the past two years, this poses a significant challenge for future treatment options for one of the most common sexually transmitted ...
Jul 20, 2026
0
3
Wistar scientists have developed a new type of bispecific T cell engager, or BTE, that is effective against ovarian cancer in preclinical studies. It's a major development for this type of immunotherapy, which has been used ...
Jul 19, 2026
0
11
